Hillsdale Investment Management Inc. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 186 filers reported holding PDL BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Hillsdale Investment Management Inc. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2018$993,000
+7.2%
337,8000.0%0.14%
-7.4%
Q4 2017$926,000
-12.9%
337,800
+7.7%
0.15%
-16.8%
Q3 2017$1,063,000
+2937.1%
313,507
+3035.1%
0.18%
+1276.9%
Q4 2015$35,000
-85.8%
10,000
-79.6%
0.01%
-84.3%
Q3 2015$246,000
-17.7%
49,000
+5.4%
0.08%
-8.8%
Q2 2015$299,000
-8.6%
46,5000.0%0.09%
+8.3%
Q1 2015$327,000
+63.5%
46,500
+79.5%
0.08%
+61.5%
Q4 2014$200,000
+108.3%
25,900
+100.8%
0.05%
+67.7%
Q3 2014$96,00012,9000.03%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2017
NameSharesValueWeighting ↓
HAYS ADVISORY LLC 1,037,600$6,672,0000.97%
Global X Management CO LLC 2,435,411$15,660,0000.86%
Advisors Asset Management, Inc. 5,373,113$34,549,0000.47%
Gotham Asset Management, LLC 7,233,838$46,514,0000.39%
TFS CAPITAL LLC 582,438$3,745,0000.37%
LOMBARDIA CAPITAL PARTNERS LLC 1,637,611$10,530,0000.36%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 95,122$611,634,0000.33%
FIRST TRUST ADVISORS LP 17,536,793$112,762,0000.29%
Arrow Investment Advisors, LLC 214,595$1,380,0000.28%
GSA CAPITAL PARTNERS LLP 954,853$6,140,0000.24%
View complete list of PDL BIOPHARMA INC shareholders